Revenue (Tables)

3 Months Ended

Mar. 31, 2023

Revenue [abstract]

Schedule of Revenue Recognized in Consolidated Statement of Profit or Loss

	Three Months Ended March 31,
	2023		2022
	(EUR’000)
Revenue from external customers
Commercial sale of products		31,551		1,888
Rendering of services		1,170		372
Sale of clinical supply		254		3,936
Licenses		614		632
Total revenue from external customers		33,589		6,828
Attributable to
Commercial customers		31,551		1,888
Collaboration partners and license agreements		2,038		4,940
Total revenue from external customers		33,589		6,828
Specified by timing of recognition
Recognized over time		1,170		372
Recognized at a point in time		32,419		6,456
Total revenue from external customers		33,589		6,828
Revenue by geographical location
Europe		—		135
North America		33,070		6,456
China		519		237
Total revenue from external customers		33,589		6,828